Macrophage Migration Inhibitory Factor Human Recombinant
Macrophage Inducing Factor Human Recombinant produced in E. coli is a single, non-glycosylated, polypeptide chain containing 115 amino acids (1-115aa) and having a molecular mass of 12kDa. MIF human Recombinant is purified by proprietary chromatographic techniques.
Macrophage Migration Inhibitory Factor Human Recombinant, His Tag C-Terminus
Macrophage Migration Inhibitory Factor Human, Recombinant His Tag N-Terminus
MIF human Recombinant, fused to 40 a.a. His-tag at N-terminus, was cloned into an E. coli expression vector and was purified to apparent homogeneity by using conventional column chromatography techniques.
Macrophage Inducing Factor Human Recombinant ( 1-115 a.a. ) is a single, non-glycosylated, polypeptide chain having a total amino acids of 155 and molecular mass of 17kDa.
Macrophage Migration Inhibitory Factor Human Recombinant (Active)
Macrophage Migration Inhibitor Factor Human Recombinant, GST tag
Macrophage Migration Inhibitory Factor Mouse Recombinant
Macrophage Migration Inhibitor Factor Mouse Recombinant, His Tag
Macrophage Migration Inhibitory Factor Rat Recombinant
Macrophage Migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine that plays a critical role in the immune system. It was first identified as a factor that inhibits the random migration of macrophages. MIF is classified as a cytokine and is also considered a hormone due to its wide range of biological activities.
Key Biological Properties: MIF is a multifunctional protein with enzymatic activities, including tautomerase and oxidoreductase activities. It is involved in various cellular processes such as cell proliferation, apoptosis, and inflammation.
Expression Patterns: MIF is constitutively expressed in various cell types, including immune cells (macrophages, T cells), endocrine cells, and epithelial cells. Its expression can be upregulated in response to stress, infection, and inflammatory stimuli.
Tissue Distribution: MIF is widely distributed in tissues throughout the body, with high levels found in the liver, kidney, lung, and brain. It is also present in the blood and other body fluids.
Primary Biological Functions: MIF plays a pivotal role in the regulation of the immune response. It is involved in the activation and recruitment of immune cells to sites of infection and inflammation. MIF also promotes the production of other pro-inflammatory cytokines, such as TNF-α and IL-1β.
Role in Immune Responses: MIF is crucial for the innate immune response, aiding in the recognition and elimination of pathogens. It enhances the phagocytic activity of macrophages and the production of reactive oxygen species (ROS) to kill invading microorganisms.
Pathogen Recognition: MIF interacts with pattern recognition receptors (PRRs) on immune cells, facilitating the detection of pathogen-associated molecular patterns (PAMPs) and initiating the immune response.
Mechanisms with Other Molecules and Cells: MIF exerts its effects through interactions with various receptors, including CD74, CXCR2, and CXCR4. These interactions trigger downstream signaling pathways that modulate immune cell functions.
Binding Partners: MIF binds to CD74, a cell surface receptor, which forms a complex with CD44 to initiate signaling cascades. It also interacts with chemokine receptors CXCR2 and CXCR4, influencing cell migration and survival.
Downstream Signaling Cascades: Upon binding to its receptors, MIF activates several signaling pathways, including the MAPK/ERK, PI3K/Akt, and NF-κB pathways. These pathways regulate gene expression, cell proliferation, and inflammatory responses.
Regulatory Mechanisms Controlling Expression and Activity: MIF expression is regulated at both the transcriptional and post-transcriptional levels. Various transcription factors, such as NF-κB and AP-1, bind to the MIF promoter and enhance its transcription in response to inflammatory stimuli.
Transcriptional Regulation: The MIF gene promoter contains binding sites for several transcription factors that modulate its expression. Inflammatory cytokines and stress signals can activate these transcription factors, leading to increased MIF production.
Post-Translational Modifications: MIF undergoes post-translational modifications, including phosphorylation and acetylation, which can influence its stability, localization, and activity.
Biomedical Research: MIF is a target of interest in various fields of biomedical research, including immunology, oncology, and infectious diseases. Studies on MIF contribute to understanding its role in disease pathogenesis and identifying potential therapeutic targets.
Diagnostic Tools: Elevated levels of MIF have been associated with several diseases, including autoimmune disorders, cancer, and sepsis. Measuring MIF levels in biological samples can serve as a diagnostic marker for these conditions.
Therapeutic Strategies: Targeting MIF with specific inhibitors or neutralizing antibodies has shown promise in preclinical studies for treating inflammatory diseases, cancer, and infectious diseases. These therapeutic strategies aim to modulate MIF activity and reduce disease severity.
Role Throughout the Life Cycle: MIF plays a role in various stages of life, from development to aging. During embryonic development, MIF is involved in tissue differentiation and organogenesis. In adulthood, MIF contributes to immune homeostasis and response to infections.
Development to Aging and Disease: As individuals age, MIF levels and activity can change, potentially contributing to age-related diseases such as neurodegenerative disorders and chronic inflammation. Understanding MIF’s role in aging can provide insights into therapeutic interventions for age-associated conditions.